About Celagenex
Celagenex is a company based in San Ramon (United States) founded in 2019. It operates as a B2B. The company has 687 employees as of March 31, 2024. Celagenex offers products and services including Targeted Therapies and Biological Metabolites. Celagenex operates in a competitive market with competitors including Adocia, Altimmune, Carmot, BioAge Labs and Fractyl, among others.
- Headquarter San Ramon, United States
- Employees 687 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Celagenex Research (India) Private Limited
- Date of Incorporation 09 Oct, 2019
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$11.97 M (USD)102.26as on Mar 31, 2024
-
Net Profit
-$369.86 K (USD)-13.22as on Mar 31, 2024
-
EBITDA
-$332.01 K (USD)30.53as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
687
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celagenex
Celagenex offers a comprehensive portfolio of products and services, including Targeted Therapies and Biological Metabolites.
Therapies for neuronal and cardiac health improvements.
Compounds regulating cellular metabolism for disease management.
Funding Insights of Celagenex
Detailed funding history for Celagenex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celagenex
Investment portfolio details for Celagenex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celagenex
Detailed financials for Celagenex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celagenex Comparisons
Peer comparison for Celagenex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celagenex
Celagenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Altimmune, Carmot, BioAge Labs and Fractyl, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| Locked | Locked | Locked |
Disease-modifying therapies for metabolic diseases are developed.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
|
| Locked | Locked | Locked |
Peptide-based therapies for obesity and cardiometabolic disorders are developed.
|
Detailed competitors of Celagenex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celagenex
Complete news archive for Celagenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celagenex
Celagenex was founded in 2019.
Celagenex is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
As of Mar 31, 2024, the latest employee count at Celagenex is 687.
Annual revenue of Celagenex is $11.97M as on Mar 31, 2024.
Celagenex focuses on developing cutting-edge technologies that combine biological metabolites to manage chronic lifestyle diseases like diabetes and Alzheimers. The company conducts research in neuronal, cardiac, and hepatic health, holding multiple patents for therapies that improve cognition and reduce disease impacts. Based in the US and India, they engage in licensing opportunities and target global health challenges through evidence-based innovations, without direct consumer sales.
Celagenex's top competitors include Adocia, BioAge Labs and Fractyl.
Celagenex offers Targeted Therapies and Biological Metabolites.